Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.06 CHF | -2.69% | -3.82% | -7.65% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.65% | 113M | |
+13.23% | 9.23B | |
-13.75% | 5B | |
+41.51% | 4.46B | |
+4.51% | 3.95B | |
+21.10% | 2.44B | |
-15.23% | 2.54B | |
-25.12% | 2.36B | |
+19.51% | 2.18B | |
+5.11% | 1.67B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals, ReveraGen Seek US FDA's New Drug Approval For Vamorolone